In MS, a curcumin nano formulation improved EDSS score, reduced inflammatory mediators, miRNAs, IFN-γ, CCL2, and CCL5, and increased Sox2, Sirtuin-1, Foxp3, PDCD1 (397). The gene discussed is IFNG; the disease is myeloid sarcoma.